The Probable Mechanism of Streptomycin Action in Tuberculosis *
نویسندگان
چکیده
The mechanism of streptomycin action in tuberculosis still appears to be an open question. Although from the first suggestion of its use for treating tuberculous man, it was taken for granted that its action was simply that of a tuberculostatic agent in vivo, simulating the action noted in vitro in certain culture tests under definitely established conditions. There were a few enthusiasts who led one to infer that streptomycin could kill tubercle bacilli readily and directly in vivo5 as well as in vitro.7 Such simple action would certainly prove highly desirable in achieving a cure for tuberculosis, but unfortunately it takes into little account the multiple problems involved in the various reactions of the tubercle bacillus and the similarities upon which are based its parasitism in the human or animal body. These mechanisms are also far from being completely elucidated. Extreme caution is necessary to avoid hasty deductions, if past experiences with the tubercle bacillus and tuberculosis are used as evidence. In a preliminary report2 in 1946, it was pointed out that: Streptomycin properly administered and in proper dosage is capable of retarding the development or growth of human tubercle bacilli both in vitro... and in vivo. The concentration of streptomycin required to retard the growth of tubercle bacilli in vitro in good nutrient mediums can only be attained in vivo for a brief period by any route of administration or amount of streptomycin that can be used. There is no evidence available . . . to indicate that streptomycin enters the important organs in appreciable amount for any significant time, although it is present in the blood, or that it accumulates in these organs. There is no evidence that tubercle bacilli adsorb or absorb streptomycin or that it accumulates in these bacilli in vitro or in vivo. In 1947 it was further noted4 that: "Streptomycin cannot be considered a cure for tuberculosis in man at present since it is incapable of destroying virulent human tubercle bacilli or of completely retarding their development in vivo under the best experimental conditions. In experimental virulent infection, streptomycin is capable of retarding tuberculosis, but it is incapable of completely negating a lethal issue from such infection." Still later, it was recorded3 that "Streptomycin does
منابع مشابه
Streptomycin induced protein expression analysis in Mycobacterium tuberculosis by two-dimensional gel electrophoresis & mass spectrometry.
BACKGROUND & OBJECTIVES The resistance of Mycobacterium tuberculosis to streptomycin, a core drug for treatment of category II tuberculosis (TB) has posed a major challenge to the health providers as well as research workers worldwide and has severely compromised the therapeutic options. A significant proportion of streptomycin resistant M. tuberculosis isolates failed to show mutations in conv...
متن کاملSynthesis and anti-tubercular activity of 6-Substtitutedaryl-4-Arylidene-4,5-dihydropyridazin-3(2H)-one derivatives against Mycobacterium tuberculosis
Pyridazine plays a significant role in pharmaceuticals particularly in the field of medicinal chemistry. Several 4-substituted-benzylidene-6-substituted-phenyl-dihydro-pyridazin-3(2H)-one derivatives (3a-q) were synthesized and evaluated for their antimicrobial activities with an aim to obtain promising antitubercular agents. In the first step, 6-aryl-tetrahydro-pyridazin-3-ones (2) were prepar...
متن کاملHepatoprotective Activity of Camellia Sinensis and Its Possible Mechanism of Action
The present study appraised the hepatoprotective activity of aqueous extract of Camellia sinensis leaves and its possible mechanism of action against carbon-tetrachloride-induced liver damage. Liver damage was induced by intraperitoneal administration of equal mixture of carbon tetrachloride and olive oil (50 % v/v, 0.5 ml/kg ) in male Wistar rats (150-220g) once daily for...
متن کاملDevelopment of 1,2,4-triazole-5-thione derivatives as potential inhibitors of enoyl acyl carrier protein reductase (InhA) in tuberculosis.
Tuberculosis (TB) ranks second, next to AIDS making it most formidable disease if the present age. One of the crucial enzymes involved in cell wall synthesis of Mycobacterium tuberculosis, InhA (enoyl acyl carrier protein reductase) has been authenticated as an effective target for anti-mycobacterial drug development. In the current work, we have developed novel derivatives of 1,2,4-triazole-5-...
متن کاملCHILDHOOD RESPIRATORY TUBERCULOSIS IN IRAN
To estimate the bacterio-epidemiological situation of childhood respiratory tuberculosis in Iran, 2185 symptomatic patients of 0-14 years old were studied. Among 110 bacteriologically confirmed cases, 60% were less than five years old and the number of females was slightly more than males. In 21 % of patients, the Mantoux test was negative. None of the miliary cases had a history of BCG va...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Yale Journal of Biology and Medicine
دوره 21 شماره
صفحات -
تاریخ انتشار 1949